Skip to content
AwardedSpainGoods€2,502,317

Suministro de medicamentos exclusivos con principios activos avelumab, cetuximab, cladribina, interferon beta-1A y tepotinib

Published
Published 22 July 2025

Overview

Suministro de medicamentos exclusivos con principios activos avelumab, cetuximab, cladribina, interferon beta-1A y tepotinib

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€2,502,317
Procedure
Direct
Published
22 July 2025
Classification (CPV)
Antineoplastic and immunomodulating agentsImmunosuppressive agents

Award outcome

Awarded value
€7,775,823
Award date
26 June 2025
Winner
  • MERCK, S.L.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    22 July 2025

Contracting authority

  • Servicio Murciano de Salud - Junta de Compras

    Procuring entity

    Espinardo, Spain

    ID_PLATAFORMA: 41261690169929

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro de medicamentos exclusivos con principios activos avelumab, cetuximab, cladribina, interferon beta-1A y tepotinib — won by MERCK, S.L. — Skim